DownSyndrome Achieves Completes Delivery of Biosamples for Study Investigating Prevalence of Eye Disease in People with DS

DownSyndrome Achieves is pleased to announce it has completed the delivery of 100 blood plasma and serum samples for an NIH-funded R21 study on keratoconus dystrophy (KD) and Down syndrome at the University of North Texas Health Science Center at Fort Worth.Keratoconus dystrophy is a corneal disease that affects more...